To validate the multi-omics-identified targets in Rb, we first performed immunohistochemical staining on the same set of advanced and non-advanced Rb tumor tissues, using pediatric retina as the controls to evaluate the classical molecular signs. The gene discussed is RB1; the disease is retinoblastoma.